Maria Finch, NP-C
NPI 1376916296 · Nurse Practitioner · Wilmington, NC
Enrolled with Medicare as Practitioner - Nurse Practitioner · source: CMS PECOS Public Provider Enrollment (2026.04.01)
Provider details
- NPI number
- 1376916296
- Entity type
- Individual
- Primary specialty
- Nurse PractitionerPhysician Assistants & Advanced Practice Nursing Providers
- Credential
- NP-C
- Sex
- Female
- Sole proprietor
- No
- License
- 5008081 (NC)
Specialties & taxonomies
Physician Assistants & Advanced Practice Nursing Providers
Profile Score
A profile completeness & documented-activity index — NOT a quality, outcomes, or patient-satisfaction rating.
- Registry tenure25% of score
10 yrs in NPPES registry
- Profile completeness25% of score
100% of core fields populated
- Practice footprint15% of score
1 documented practice location
- Medicare service volume (vs. specialty peers)25% of score
1,755 Medicare services, 2024 (ranked within specialty)
- Open Payments transparency10% of score
Has Open Payments disclosures (2024)
Medicare volume is ranked against active providers in the same specialty. Signals a provider has no public data for (e.g. Medicare claims) are left out of the score entirely — never counted as zero — so providers without that data are not penalized. See the full formula and weights in our .
What this provider does (Medicare)
Based on Medicare fee-for-service claims, 2024; not all care is captured.
| Service (HCPCS) | Medicare services | Typical Medicare-allowed (2024) |
|---|---|---|
| Established Patient Office Or Other Outpatient Visit With Moderate Level of Decision Making, If Using Time, 30 Minutes Or More99214 | 853 | $102 |
| Established Patient Office Or Other Outpatient Visit With Low Level OD Decision Making, If Using Time, 20 Minutes Or More99213 | 208 | $72 |
| Test to Examine How Well the Lungs Exchange Gases94729 | 168 | $44 |
| Test to Measure Expiratory Airflow and Volume Changes Before and After Medication Administration94060 | 163 | $31 |
| Test to Determine Lung Volumes Using Sensors94726 | 159 | $44 |
| Visit Complexity Inherent to Evaluation and Management Associated With Medical Care Services That Serve As the Continuing Focal Point for All Needed Health Care Services And/Or With Medical Care Services That Are Part of Ongoing Care Related to a Patient'S |
What this provider prescribes (Medicare Part D)
Top drugs by Medicare Part D claim volume, 2024 · 33 distinct drugs on file.
| Drug | Part D claims (2024) | Beneficiaries |
|---|---|---|
| Fluticasone/Umeclidin/Vilanterbrand: Trelegy Ellipta | 842 | 140 |
| Albuterol Sulfatebrand: Albuterol Sulfate Hfa | 554 | 167 |
| Montelukast Sodium | 289 | 80 |
| Prednisone | 274 | 119 |
| Fluticasone/Vilanterolbrand: Breo Ellipta | 196 | 50 |
| Umeclidinium Brm/Vilanterol Trbrand: Anoro Ellipta | 170 | 35 |
Transparency — industry payments
Based on CMS Open Payments, 2024; not all care is captured.
$2,789 across 145 records (Open Payments 2024)
Open Payments discloses payments and transfers of value (meals, travel, consulting, research, royalties) from drug and device makers to providers. This is a transparency signal, not a verdict — such payments are legal and common, and their presence is neither an endorsement nor a criticism. Source: CMS Open Payments, program year 2024.
Practice location
Mailing address
Registry dates
- Enumerated
- 2015-11-02
- Last updated
- 2024-09-09
- Certified
- 2024-09-09
Source: CMS NPPES Data Dissemination (June 2026). NPI Central is not affiliated with CMS. Data is provided as-is from the public registry.